Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.

@article{Goto2001HistopathologyN,
  title={Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.},
  author={Shigenori Goto and Shintaro Umehara and Robert B. Gerbing and Daniel O. Stram and Garrett M. Brodeur and Robert C. Seeger and John Nicholas Lukens and Katherine K. Matthay and Hiroyuki Shimada},
  journal={Cancer},
  year={2001},
  volume={92 10},
  pages={2699-708}
}
BACKGROUND The International Neuroblastoma Pathology Classification (International Classification), which was established in 1999, is significant prognostically and is relevant biologically for the evaluation and analysis of patients with neuroblastic tumors (NTs). MYCN amplification is a known molecular marker for aggressive progression of NTs. These have been used together as important prognostic factors to define risk groups for patient stratification and protocol assignment. METHODS A… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 48 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 48 references

Similar Papers

Loading similar papers…